Bain Capital Life Sciences Investors, LLC
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1703031
Boston, MA
Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$131,141,499
-$104,745,657 QoQ
Shares Held
3,906,565
-47.3% QoQ
Ownership
3.27%
of shares outstanding
% of Portfolio
7.80%
of 13F equity value
Holder Rank
#8
of 198 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bain Capital Life Sciences Investors, LLC holds $1,318,022,438 across 17 Biotechnology names. NAMS ranks #2 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KLRA |
Kailera Therapeutics, Inc.
|
22,583,268 | $497,509,394 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
3,906,565 | $131,141,499 | |
| 3 | SVRA |
Savara Inc
|
17,600,621 | $108,419,825 | |
| 4 | SLDB |
Solid Biosciences Inc.
|
9,808,819 | $97,990,101 | |
| 5 | PHVS |
Pharvaris N.V.
|
2,675,509 | $92,519,101 | |
| 6 | OLMA |
Olema Pharmaceuticals, Inc.
|
7,085,249 | $88,636,464 | |
| 7 | COAG |
Hemab Therapeutics Holdings, Inc.
|
1,650,000 | $60,604,500 | |
| 8 | CABA |
Cabaletta Bio, Inc.
|
17,241,445 | $53,620,893 |
All Filings in NAMS
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 NAMSW | $2,136,978 | 99,999 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $129,004,521 | 3,806,566 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 NAMSW | $2,003,979 | 99,999 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $233,883,177 | 7,306,566 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 NAMSW | $2,299,977 | 99,999 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $256,314,335 | 7,306,566 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 NAMSW | $1,711,000 | 100,000 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $304,851,488 | 10,719,110 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 NAMSW | $800,000 | 100,000 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $194,123,082 | 10,719,110 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 NAMSW | $899,000 | 100,000 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $219,420,181 | 10,719,110 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 NAMSW | $1,425,000 | 100,000 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $275,481,127 | 10,719,110 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 NAMSW | $700,000 | 100,000 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $173,866,955 | 10,473,913 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 NAMSW | $872,000 | 100,000 | Shares | Sole | 2024-08-12 | |
| 2024-06-30 | $201,203,868 | 10,473,913 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 NAMSW | $1,104,000 | 100,000 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $247,708,042 | 10,473,913 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 NAMSW | $313,000 | 100,000 | Shares | Sole | 2024-02-13 | |
| 2023-12-31 | $116,993,608 | 10,473,913 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 NAMSW | $190,000 | 100,000 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $96,883,695 | 10,473,913 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 NAMSW | $209,000 | 100,000 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $124,534,825 | 10,473,913 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 NAMSW | $184,000 | 100,000 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $110,058,000 | 8,300,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 NAMSW | $86,800 | 100,000 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $90,470,000 | 8,300,000 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||